MVIR:STO
Medivir AB
SEK 1,66
arrow_downward
-0,72%(-0,012) 1D
29 de set., 12:11:22 GMT+2 · SEK
search
Todos os ativos
1D
5D
1M
6M
YTD
1A
5A
MÁX
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para MVIR…
Abrir
SEK 1,65
Alta
SEK 1,66
Baixa
SEK 1,64
Valor de mercado
1,04 bi
Volume médio
1,97 mi
Volume
376,31 mil
Alto — 52 sem
SEK 2,88
Baixo — 52 sem
SEK 0,34
LPA
-SEK 0,37
Ações em circulação
624,04 mi
Nº de funcionários
6
Abrir
SEK 1,65
Alta
SEK 1,66
Baixa
SEK 1,64
Valor de mercado
1,04 bi
Volume médio
1,97 mi
Volume
376,31 mil
Alto — 52 sem
SEK 2,88
Baixo — 52 sem
SEK 0,34
LPA
-SEK 0,37
Ações em circulação
624,04 mi
Nº de funcionários
6
Perfil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Sobre Medivir AB